News & Events
UCL is awarded £4m from the Wellcome Trust to fight Sepsis
The Wellcome Trust has announced it will invest £4million into a programme to develop UCL's patented series of selective DDAH inhibitors for use in treating sepsis. This award has recognised both the urgent need for effective therapies for this condition, and the strong potential of the project team’s unique approach.
Full Story
UCL Business concludes £multi-million sale of Stanmore Implants
UCL Business today announces the sale of Stanmore Implants Worldwide for around £10million, to a syndicate led by Abingworth
Management and MDY Healthcare plc. Stanmore Implants Worldwide is an innovative orthopaedic business focused on saving and restoring the function of limbs and joints.
Full Story
UCL leads Key Collaboration to Enhance Gene Discovery Findings in Schizophrenia
UCL has entered into a research collaboration to replicate the findings of a genome-wide association study carried out by Genizon Inc. of Quebec, under an agreement between the Canadian company and London Genetics Ltd.
Full Story
Globe Theatre hosts the London Project to Cure Blindness
On the 16th January, visitors to the Globe Theatre had a chance to experience some of the daily difficulties faced by blind people in an event that highlighted the problems with Age-related Macular Degeneration (AMD), and the exciting work of the London Project to Cure Blindness, that is aiming to provide a cure for many of its sufferers.
Full Story
UCL Biomedical Breakthroughs Draw Crowds at Genesis VII
This year’s Genesis Conference witnessed a first-of-its-kind UCL Biomedical Innovation Showcase presenting a number of novel, life-changing technologies available for collaboration or license.
Full Story
